Since PET imaging with 18FDG is only a measure of glucose uptake and not glucose oxidation, hyperpolarized 13C MRS studies would be a better approach to determine whether GLP-1R agonists increase cardiac glucose oxidation in humans with T2D as they do in animals. Here, GLP1R is linked to type 2 diabetes mellitus.